Shares of Johnson Matthey PLC (LON:JMAT - Get Free Report) hit a new 52-week high during trading on Thursday . The company traded as high as GBX 1,950 ($26.39) and last traded at GBX 1,913 ($25.89), with a volume of 705148 shares trading hands. The stock had previously closed at GBX 1,920 ($25.99).
Wall Street Analyst Weigh In
Separately, Berenberg Bank upped their target price on shares of Johnson Matthey from GBX 1,800 to GBX 1,950 and gave the stock a "hold" rating in a report on Monday, July 21st. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of GBX 1,875.
Read Our Latest Analysis on JMAT
Johnson Matthey Price Performance
The business's 50 day moving average price is GBX 1,849.97 and its 200 day moving average price is GBX 1,591.18. The stock has a market capitalization of £3.22 billion, a P/E ratio of 909.09, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95. The company has a debt-to-equity ratio of 62.73, a current ratio of 1.45 and a quick ratio of 0.76.
Insiders Place Their Bets
In related news, insider Andrew Cosslett bought 10,495 shares of the stock in a transaction dated Tuesday, August 26th. The shares were purchased at an average price of GBX 1,896 per share, with a total value of £198,985.20. Insiders have purchased a total of 10,523 shares of company stock worth $19,947,408 over the last quarter. 0.50% of the stock is owned by insiders.
About Johnson Matthey
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.